Pharmaceuticals

Peptide Therapeutics Industry Insights: Market Forecast to 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Peptide Therapeutics Market Expected To Become By 2029 Compared With Its 2025 Level?

The peptide therapeutics market size has experienced robust growth recently. This market is projected to expand from $45.15 billion in 2024 to reach $49.21 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 9.0%. Historically, this expansion has been driven by factors such as the increasing incidence of chronic diseases, a growing understanding of molecular biology, and expanding applications in oncology.

The peptide therapeutics market is projected for significant expansion over the coming years, reaching $74.98 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.1%. This growth is primarily driven by factors such as the increasing need for personalized medicine, broader applications in immunotherapy, continuous improvements in peptide delivery systems, the identification of new peptide targets for infectious diseases, and a heightened focus on rare diseases. Key trends anticipated during this period include technological progress in peptide synthesis, an uptick in investment and funding, a strong emphasis on the safety of peptide drugs, market penetration into developing economies, and the incorporation of artificial intelligence (AI).

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7216&type=smp

Which Major Market Drivers Are Shaping The Future Of The Peptide Therapeutics Market?

The rising occurrence of chronic illnesses is anticipated to fuel the expansion of the peptide therapeutics market. These are enduring health conditions that frequently lack a cure, though they can sometimes be managed or even overcome. The escalating incidence of chronic diseases stems from factors such as heightened tobacco product consumption, inadequate nutrition, lack of physical activity, excessive alcohol intake, among other contributors. Peptide therapeutics offer assistance in both preventing and treating specific chronic conditions. For example, data released in January 2023 by the US-based National Library of Medicine indicates that by 2050, the population in the US aged 50 and older suffering from at least one chronic condition is projected to rise by 99.5%, reaching 142.66 million individuals. Consequently, the growing prevalence of chronic diseases is set to propel the peptide therapeutics market throughout the projected timeframe.

How Is The Peptide Therapeutics Market Segmented?

The peptide therapeutics market covered in this report is segmented –

1) By Type: Generic, Branded

2) By Route of Administration: Parenteral, Mucosal, Oral, Transdermal

3) By Application: Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications

Subsegments:

1) By Generic: Generic Peptide Drugs, Biosimilars

2) By Branded: Innovative Peptide Drugs, Patent-Protected Peptides

What Trends Are Expected To Drive The Peptide Therapeutics Market?

Leading companies in the peptide therapeutics market are concentrating on introducing advanced solutions, such as cell culture processes, to gain a competitive edge. This cell culture process involves cultivating cells outside their natural environment under controlled conditions, which includes isolating cells of interest from living tissue and subsequently maintaining them. For instance, in June 2023, Evonik Industries AG, a German-based specialty chemicals company, launched cQrex KC. cQrex KC is a next-generation peptide for biopharma applications designed for the cell culture process used in the manufacture of biological drugs. It enables cell culture process developers to optimize cystine supply and increase cell culture productivity. Additionally, cQrex KC supports the development of vaccines, viral vectors, and cell therapies.

Who Are The Key Multinational Companies Dominating The Peptide Therapeutics Market?

Major companies operating in the peptide therapeutics market include Pfizer Inc., Jhonson & Jhonson, Abbvie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk AS, Teva Pharmaceuticals Industries Ltd., Bachem Holding AG, PolyPeptide Laboratories BV, Arcus Biosciences Inc., Pepscan Therapeutics, Peptech Inc., Peptide Logic Inc., SELLAS Life Sciences Group, Ever Neuro Pharma GmbH, Zealand Pharma AG, PepGen Inc., Pepticom S.A., Peptide Technologies Corporation, SynPeptide Inc., Peptimmune Inc., Merck & Co Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Peptide Therapeutics Market?

North America was the largest region in the peptide therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Peptide Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=7216&type=smp

Browse Through More Reports Similar to the Global Peptide Therapeutics Market 2025, By The Business Research Company

Biosimilar Therapeutic Peptide Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biosimilar-therapeutic-peptide-global-market-report

Nutraceuticals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nutraceuticals-global-market-report

Oral Biologics And Biosimilars Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilars-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795